AJP - Lung Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 291: L289-L295, 2006; doi:10.1152/ajplung.00343.2005
1040-0605/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobson, J. R.
Right arrow Articles by Garcia, J. G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobson, J. R.
Right arrow Articles by Garcia, J. G. N.

Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin

Jeffrey R. Jacobson, Steven M. Dudek, Patrick A. Singleton, Irina A. Kolosova, Alexander D. Verin, and Joe G. N. Garcia

Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois

Submitted 4 August 2005 ; accepted in final form 20 February 2006

ATP is a physiologically relevant agonist released by various sources, including activated platelets, with complex effects mediated via activation of P2 purinergic receptors. ATP-induced endothelial cell (EC) production of prostacyclin and nitric oxide is recognized, and EC barrier enhancement evoked by ATP has been described. ATP effects on EC barrier function and vascular permeability, however, remain poorly characterized. Although the mechanisms involved are unclear, we previously identified activation of the small GTPase Rac and translocation of cortactin, an actin-binding protein, as key to EC barrier augmentation induced by simvastatin and sphingosine 1-phosphate and therefore examined the role of these molecules in ATP-induced EC barrier enhancement. ATP induced rapid, dose-dependent barrier enhancement in human pulmonary artery EC as measured by transendothelial electrical resistance, with a peak effect appreciable at 25 min (39% increase, 10 µM) and persisting at 2 h. These effects were associated with rearrangement of the EC actin cytoskeleton, early myosin light chain phosphorylation, and spatially defined (cell periphery) translocation of both Rac and cortactin. ATP (10 µM)-treated EC demonstrated a significant increase in Rac activation relative to controls, with a maximal effect (~4-fold increase) at 10 min. Finally, ATP-induced barrier enhancement was markedly attenuated by reductions of either Rac or cortactin (small interfering RNA) relative to controls. Our results suggest for the first time that ATP-mediated barrier protection is associated with cytoskeletal activation and is dependent on both Rac activation and cortactin.

vascular permeability; cytoskeleton; actin



Address for reprint requests and other correspondence: J. G. N. Garcia, Pritzker School of Medicine, Univ. of Chicago, 5841 S. Maryland Ave., MC6092 AMBW604, Chicago, IL 60637 (e-mail: jgarcia{at}medicine.bsd.uchicago.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. Chen, S. Pendyala, V. Natarajan, J. G. N. Garcia, and J. R. Jacobson
Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition
Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L575 - L583.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. P. Tobin, G. T. Henehan, R. P. Murphy, J. C. Atherton, A. F. Guinan, S. W. Kerrigan, D. Cox, P. A. Cahill, and P. M. Cummins
Helicobacter pylori-induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1403 - H1413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. A. Kolosova, T. Mirzapoiazova, L. Moreno-Vinasco, S. Sammani, J. G. N. Garcia, and A. D. Verin
Protective effect of purinergic agonist ATP{gamma}S against acute lung injury
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L319 - L324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Csortos, I. Kolosova, and A. D. Verin
Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L843 - L854.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. K. Sumanasekera, G. U. Sumanasekera, K. A. Mattingly, S. M. Dougherty, R. S. Keynton, and C. M. Klinge
Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C566 - C573.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.